Streetbeat News

Products Services

LLY

Eli Lilly presented updated data from its Phase 1/2 study for KRAS G12C-mutant solid tumors at ASCO 2024. The data showed promising monotherapy activity with olomorasib and a good tolerability profile in combination with pembrolizumab, making it suitable for first-line lung cancer development.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:21 am

BMY

Bristol Myers Squibb's KRAZATI showed significant improvement in progression-free survival in a Phase 3 study for KRASG12C-mutated advanced NSCLC, as presented at the 2024 ASCO Annual Meeting.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:11 am

ORAN

Haier Europe has partnered with Orange Business to leverage its connectivity and IoT services for sustainable innovation and resource optimization. This collaboration aims to support Haier's transformation into a data-driven enterprise with a focus on smart home solutions.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:08 am

HIMX

NVDA

Himax Technologies is integrating its WiseEye Ultralow Power AI Sensing solution with NVIDIA's TAO platform to enhance AI vision deployment for enterprises and battery-powered devices. This integration aims to provide advanced, low-power AI capabilities for on-device applications.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 8:05 am

NVDA

Elon Musk's AI company xAI plans to invest in Nvidia's next-generation AI chips, the Blackwell B200s, highlighting Nvidia's market dominance. Analyst Pierre Ferragu emphasizes the significant performance and cost improvements of the B200s over the H100s. Nvidia's AI infrastructure is in high demand, with major clients like Microsoft, Meta, and Google increasing their capital expenditures.

Portfolio Pulse from Ananya Gairola

June 03, 2024 | 8:03 am

HYMTF

Hyundai Motor America reported a 12% year-over-year increase in May 2024 sales and a 2% increase in year-to-date total sales. The company saw its best May sales for several models, including the IONIQ 5, IONIQ 6, Tucson HEV, Santa Fe HEV, Palisade, and Santa Cruz. Retail sales in May were up 9% year-over-year, with significant contributions from the Palisade, IONIQ 5, and Santa Fe HEV. Additionally, May EV sales surged by 42% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 7:54 am

BNBUSD

DOGEUSD

SOLUSD

TONUSD

Notcoin (NOT) and Toncoin (TON), cryptocurrencies linked to Telegram, saw significant gains with NOT becoming the fourth-most traded crypto. NOT's trading volume spiked 141% to $4.43 billion, surpassing Solana (SOL) and Dogecoin (DOGE). The surge is attributed to the success of a Telegram-based game and the growth of the TON ecosystem.

Portfolio Pulse from Aniket Verma

June 03, 2024 | 7:51 am

BDTX

Black Diamond Therapeutics presented promising clinical data for BDTX-1535 in patients with recurrent glioblastoma at the 2024 ASCO Annual Meeting. The Phase 1 trial showed favorable safety, tolerability, and encouraging anti-tumor activity, while the Phase 0/1 trial indicated clinically meaningful drug levels in brain tumor tissue.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 7:47 am

WTW

WTW has launched Climate Quantified Technology, a SaaS tool designed to quantify the financial impact of climate change on companies with high precision. This tool assesses physical and transition risks, supply chain vulnerabilities, and regulatory changes, providing a comprehensive analysis to support strategic decision-making.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 7:36 am

CRBP

Corbus Pharmaceuticals announced that their drug SYS6002 (CRB-701) continues to show safety and efficacy in treating Nectin-4 positive tumors, according to an ASCO 2024 clinical update. The drug demonstrated significant ORR and DCR in both mUC and cervical cancer patients, with no dose-limiting toxicities observed up to 4.5 mg/Kg.

Portfolio Pulse from Benzinga Newsdesk

June 03, 2024 | 7:21 am